Endocrine oncology

Are Total Thyroidectomy and Adjuvant Radioactive Iodine Treatment Required in All Patients with N1b Intermediate-High Risk Papillary Thyroid Carcinoma?

ThyroidPublished Retrospective cohort study

Authors' conclusion

RAI may improve RFS in selected patients with extensive nodal disease, but its routine use in all cN1b PTC cases may be unnecessary. Lobectomy or total thyroidectomy without RAI could be appropriate options in lower risk cN1b patients. Further studies are warranted to refine treatment strategies in intermediate-risk cN1b PTC.

Study context

Population
Patients with cT1–3N1bM0 PTC who underwent thyroidectomy with therapeutic lateral neck dissection, 2010–2022; 60.6% female, median age 58.0 years
Participants
593 patients
Exposure
Lobectomy vs total thyroidectomy vs total thyroidectomy with RAI, each with lateral neck dissection
Outcome
Recurrence-free survival (RFS) and disease-specific survival (DSS)
Follow-up
Median 71.5 months
Methodological detailsmulticenter
  • Multicenter

Main finding

As reported in the abstract

  • Total thyroidectomy with RAI showed a trend toward worse recurrence-free survival (RFS), not statistically significant
  • Between Lobectomy and Total thyroidectomy: P = 0.19
  • Between Lobectomy and Total thyroidectomy: P = 0.40
  • Comparison across lobectomy, total thyroidectomy and total thyroidectomy with RAI (Kaplan-Meier)

Observational data: associations, not effects.

Further findings

Independent risk factors for shorter RFS (multivariable Cox)

Older age, HR per year
1.024 (CI 1.007-1.041, p = 0.006)
Larger primary tumor size, HR per mm
1.026 (CI 1.012-1.041, p < 0.001)
Larger metastatic lymph node size, HR per mm
1.020 (CI 1.003-1.036, p = 0.017)
Extranodal extension, HR
1.741 (CI 1.046-2.898, p = 0.033)

Original publication

Are Total Thyroidectomy and Adjuvant Radioactive Iodine Treatment Required in All Patients with N1b Intermediate-High Risk Papillary Thyroid Carcinoma? Thyroid. Published 4 December 2025. doi:10.1177/10507256251401241

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.